Remove Bioassay Remove Bioinformatics Remove Engineer Remove Gene Editing
article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

Sphere Fluidics presence on the exhibition floor was bolstered by a presentation from Richard Hammond: ‘Picodroplets for cell Line engineering: A novel automation approach’. It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’.